Showing results (111-120 of 171) with videos related to
Sort By:
Pageof 18
Neurobiology of Disease|September 6, 2011
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effectSuzana Gispert, Alexander Kurz, Stefan Waibel, et al.Human Molecular Genetics|February 5, 2011
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsTeresa Lee, Yun R Li, Caroline Ingre, et al.Biorxiv : the Preprint Server for Biology|April 27, 2026
Whole-genome 3D architectural screen reveals modulators of brain DNA structureBibudha Parasar, Achuthan Raja Venkatesh, Jonathan Perera, et al.Nucleic Acids Research|May 29, 2020
A memory of eS25 loss drives resistance phenotypesAlex G Johnson, Ryan A Flynn, Christopher P Lapointe, et al.Biorxiv : the Preprint Server for Biology|July 17, 2025
KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALSTetsuya Akiyama, Yi Zeng, Caiwei Guo, et al.Neuron|December 24, 2014
Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synucleinNripesh Dhungel, Simona Eleuteri, Ling-Bo Li, et al.Plos One|April 12, 2011
PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeatsZhenming Yu, Yongqing Zhu, Alice S Chen-Plotkin, et al.Nature|April 14, 2017
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 miceLindsay A Becker, Brenda Huang, Gregor Bieri, et al.Biomedicines|January 21, 2022
Phenotypic Heterogeneity among GBA p.R202X Carriers in Lewy Body Spectrum DisordersValerio Napolioni, Carolyn A Fredericks, Yongha Kim, et al.Nature Communications|October 27, 2021
CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and miceD Halperin, A Stavsky, R Kadir, et al.Pageof 18